Loading…
Complications of type 2 diabetes mellitus in Ramallah and al-Bireh: The Palestinian Diabetes Complications and Control Study (PDCCS)
•Persons with type 2 diabetes in 11 primary health care clinics were sampled.•Over three-quarters of the participants had at least one complication.•67% had at least one microvascular and 29% had at least 1 macrovascular complication.•Around one fifth of the participants had good glycemic control (H...
Saved in:
| Published in: | Primary care diabetes 2018-12, Vol.12 (6), p.547-557 |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c464t-c0336b6cf2cbd37647238204910def385c93fc2c4753cac172effd221677dd893 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c464t-c0336b6cf2cbd37647238204910def385c93fc2c4753cac172effd221677dd893 |
| container_end_page | 557 |
| container_issue | 6 |
| container_start_page | 547 |
| container_title | Primary care diabetes |
| container_volume | 12 |
| creator | Ghandour, Rula Mikki, Nahed Abu Rmeileh, Niveen M.E. Jerdén, Lars Norberg, Margareta Eriksson, Jan W. Husseini, Abdullatif |
| description | •Persons with type 2 diabetes in 11 primary health care clinics were sampled.•Over three-quarters of the participants had at least one complication.•67% had at least one microvascular and 29% had at least 1 macrovascular complication.•Around one fifth of the participants had good glycemic control (HbA1c |
| doi_str_mv | 10.1016/j.pcd.2018.07.002 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_DiVA_org_uu_372817</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1751991818301955</els_id><sourcerecordid>2083714571</sourcerecordid><originalsourceid>FETCH-LOGICAL-c464t-c0336b6cf2cbd37647238204910def385c93fc2c4753cac172effd221677dd893</originalsourceid><addsrcrecordid>eNqNksFu1DAURSNERUvhA9ggL4sgwc9OYqesSqYFpEpUtLC1HNthPEriENug2fPh9WjaSmyAlb049yzuu1n2AnABGOq3m2JWuiAYeIFZgTF5lB0BZzzHBPDj9GcV5E0D_DB76v0G4xooZ0-yQ4oxI4Q1R9nv1o3zYJUM1k0euR6F7WwQQdrKzgTj0WiGwYbokZ3QFznKYZBrJCeN5JC_t4tZn6KbtUFXcjA-2MnKCa3us3_Kd6HWTWFxA7oOUW_RydWqba9fPcsOejl48_zuPc6-XpzftB_zy88fPrVnl7kq6zLkClNad7Xqieo0ZXXJCOUElw1gbXrKK9XQXhFVsooqqYAR0_eaEKgZ05o39Dh7s_f6X2aOnZgXO8plK5y0YmW_nQm3fBcxCsoIB5bw_D_wMQqoUrOQ-Nf_5nUUJQDwRJ_s6XlxP2LqTozWq1S2nIyLXhDMKYOyYjsx7FG1OO8X0z-oAYvdEsRGpCWI3RIEZiItIWVe3uljNxr9kLg_fQLe7QGTGv9pzSK8smZSRqejqiC0s3_R3wKRZsPm</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2083714571</pqid></control><display><type>article</type><title>Complications of type 2 diabetes mellitus in Ramallah and al-Bireh: The Palestinian Diabetes Complications and Control Study (PDCCS)</title><source>Elsevier:Jisc Collections:Elsevier Read and Publish Agreement 2022-2024:Freedom Collection (Reading list)</source><creator>Ghandour, Rula ; Mikki, Nahed ; Abu Rmeileh, Niveen M.E. ; Jerdén, Lars ; Norberg, Margareta ; Eriksson, Jan W. ; Husseini, Abdullatif</creator><creatorcontrib>Ghandour, Rula ; Mikki, Nahed ; Abu Rmeileh, Niveen M.E. ; Jerdén, Lars ; Norberg, Margareta ; Eriksson, Jan W. ; Husseini, Abdullatif</creatorcontrib><description>•Persons with type 2 diabetes in 11 primary health care clinics were sampled.•Over three-quarters of the participants had at least one complication.•67% had at least one microvascular and 29% had at least 1 macrovascular complication.•Around one fifth of the participants had good glycemic control (HbA1c<7.0%).•89% had high blood pressure or were on anti-hypertensive medications.
Type 2 diabetes mellitus (T2DM) is a growing pandemic that will lead, if not managed and controlled, to frequent complications, poor quality of life, and high rates of disability and death. Little is known about T2DM complications in Palestine. The aim of this study is to estimate the prevalence of T2DM complications in Ramallah and al-Bireh governorate of Palestine.
The study was conducted in eleven primary healthcare clinics offering services for persons with T2DM. Macrovascular complications were assessed using the Diabetes complication index. Microvascular complications were measured by physical examinations and laboratory tests. Questionnaires, laboratory tests, and physical examinations were used to assess socio-demographic characteristics, co-morbidities and other risk factors.
517 adult men and nonpregnant women participated in the study (166 men, 351 women). The response rate was 84%. Mean age and mean duration of diabetes were 58.1 and 9.4 years respectively. Prevalence of diagnosed microvascular and macrovascular complications was 67.2% and 28.6% respectively. 78.2% of the participants had poor glycemic control (HbA1c≥7.0%).
Significant proportions of persons with T2DM had macro- and microvascular complications and poor metabolic control. These findings are important for policy development and the planning of health services.</description><identifier>ISSN: 1751-9918</identifier><identifier>ISSN: 1878-0210</identifier><identifier>EISSN: 1878-0210</identifier><identifier>DOI: 10.1016/j.pcd.2018.07.002</identifier><identifier>PMID: 30072279</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adult ; anticoagulant agent ; antidiabetic agent ; antihypertensive agent ; antilipemic agent ; Arab ; Arabs ; biological marker ; Biomarkers ; blood ; Blood Glucose ; cardiac agent ; cerebrovascular accident ; Comorbidity ; controlled study ; coronary artery disease ; Cross-Sectional Studies ; cross-sectional study ; Diabetes Complications ; Diabetes Mellitus ; diabetic complication ; diabetic nephropathy ; diabetic neuropathy ; disease duration ; epidemiology ; ethnology ; Female ; glucose blood level ; Glycated Hemoglobin A ; Glycemic control ; glycosylated hemoglobin ; Health and Welfare ; hemoglobin A1c ; hemoglobin A1c protein ; human ; Humans ; Hälsa och välfärd ; insulin ; laboratory test ; Macrovascular complications ; major clinical study ; Male ; metabolism ; Microvascular complications ; Middle Aged ; Middle East ; non insulin dependent diabetes mellitus ; Palestinian ; peripheral vascular disease ; physical examination ; Prevalence ; Primary health care clinics ; priority journal ; risk factor ; Risk Factors ; Type 2 ; Type 2 diabetes ; Young Adult</subject><ispartof>Primary care diabetes, 2018-12, Vol.12 (6), p.547-557</ispartof><rights>2018 Primary Care Diabetes Europe</rights><rights>Copyright © 2018 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c464t-c0336b6cf2cbd37647238204910def385c93fc2c4753cac172effd221677dd893</citedby><cites>FETCH-LOGICAL-c464t-c0336b6cf2cbd37647238204910def385c93fc2c4753cac172effd221677dd893</cites><orcidid>0000-0001-8995-043X ; 0000-0001-8767-5956</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30072279$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:du-41118$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-150611$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-372817$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Ghandour, Rula</creatorcontrib><creatorcontrib>Mikki, Nahed</creatorcontrib><creatorcontrib>Abu Rmeileh, Niveen M.E.</creatorcontrib><creatorcontrib>Jerdén, Lars</creatorcontrib><creatorcontrib>Norberg, Margareta</creatorcontrib><creatorcontrib>Eriksson, Jan W.</creatorcontrib><creatorcontrib>Husseini, Abdullatif</creatorcontrib><title>Complications of type 2 diabetes mellitus in Ramallah and al-Bireh: The Palestinian Diabetes Complications and Control Study (PDCCS)</title><title>Primary care diabetes</title><addtitle>Prim Care Diabetes</addtitle><description>•Persons with type 2 diabetes in 11 primary health care clinics were sampled.•Over three-quarters of the participants had at least one complication.•67% had at least one microvascular and 29% had at least 1 macrovascular complication.•Around one fifth of the participants had good glycemic control (HbA1c<7.0%).•89% had high blood pressure or were on anti-hypertensive medications.
Type 2 diabetes mellitus (T2DM) is a growing pandemic that will lead, if not managed and controlled, to frequent complications, poor quality of life, and high rates of disability and death. Little is known about T2DM complications in Palestine. The aim of this study is to estimate the prevalence of T2DM complications in Ramallah and al-Bireh governorate of Palestine.
The study was conducted in eleven primary healthcare clinics offering services for persons with T2DM. Macrovascular complications were assessed using the Diabetes complication index. Microvascular complications were measured by physical examinations and laboratory tests. Questionnaires, laboratory tests, and physical examinations were used to assess socio-demographic characteristics, co-morbidities and other risk factors.
517 adult men and nonpregnant women participated in the study (166 men, 351 women). The response rate was 84%. Mean age and mean duration of diabetes were 58.1 and 9.4 years respectively. Prevalence of diagnosed microvascular and macrovascular complications was 67.2% and 28.6% respectively. 78.2% of the participants had poor glycemic control (HbA1c≥7.0%).
Significant proportions of persons with T2DM had macro- and microvascular complications and poor metabolic control. These findings are important for policy development and the planning of health services.</description><subject>Adult</subject><subject>anticoagulant agent</subject><subject>antidiabetic agent</subject><subject>antihypertensive agent</subject><subject>antilipemic agent</subject><subject>Arab</subject><subject>Arabs</subject><subject>biological marker</subject><subject>Biomarkers</subject><subject>blood</subject><subject>Blood Glucose</subject><subject>cardiac agent</subject><subject>cerebrovascular accident</subject><subject>Comorbidity</subject><subject>controlled study</subject><subject>coronary artery disease</subject><subject>Cross-Sectional Studies</subject><subject>cross-sectional study</subject><subject>Diabetes Complications</subject><subject>Diabetes Mellitus</subject><subject>diabetic complication</subject><subject>diabetic nephropathy</subject><subject>diabetic neuropathy</subject><subject>disease duration</subject><subject>epidemiology</subject><subject>ethnology</subject><subject>Female</subject><subject>glucose blood level</subject><subject>Glycated Hemoglobin A</subject><subject>Glycemic control</subject><subject>glycosylated hemoglobin</subject><subject>Health and Welfare</subject><subject>hemoglobin A1c</subject><subject>hemoglobin A1c protein</subject><subject>human</subject><subject>Humans</subject><subject>Hälsa och välfärd</subject><subject>insulin</subject><subject>laboratory test</subject><subject>Macrovascular complications</subject><subject>major clinical study</subject><subject>Male</subject><subject>metabolism</subject><subject>Microvascular complications</subject><subject>Middle Aged</subject><subject>Middle East</subject><subject>non insulin dependent diabetes mellitus</subject><subject>Palestinian</subject><subject>peripheral vascular disease</subject><subject>physical examination</subject><subject>Prevalence</subject><subject>Primary health care clinics</subject><subject>priority journal</subject><subject>risk factor</subject><subject>Risk Factors</subject><subject>Type 2</subject><subject>Type 2 diabetes</subject><subject>Young Adult</subject><issn>1751-9918</issn><issn>1878-0210</issn><issn>1878-0210</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNqNksFu1DAURSNERUvhA9ggL4sgwc9OYqesSqYFpEpUtLC1HNthPEriENug2fPh9WjaSmyAlb049yzuu1n2AnABGOq3m2JWuiAYeIFZgTF5lB0BZzzHBPDj9GcV5E0D_DB76v0G4xooZ0-yQ4oxI4Q1R9nv1o3zYJUM1k0euR6F7WwQQdrKzgTj0WiGwYbokZ3QFznKYZBrJCeN5JC_t4tZn6KbtUFXcjA-2MnKCa3us3_Kd6HWTWFxA7oOUW_RydWqba9fPcsOejl48_zuPc6-XpzftB_zy88fPrVnl7kq6zLkClNad7Xqieo0ZXXJCOUElw1gbXrKK9XQXhFVsooqqYAR0_eaEKgZ05o39Dh7s_f6X2aOnZgXO8plK5y0YmW_nQm3fBcxCsoIB5bw_D_wMQqoUrOQ-Nf_5nUUJQDwRJ_s6XlxP2LqTozWq1S2nIyLXhDMKYOyYjsx7FG1OO8X0z-oAYvdEsRGpCWI3RIEZiItIWVe3uljNxr9kLg_fQLe7QGTGv9pzSK8smZSRqejqiC0s3_R3wKRZsPm</recordid><startdate>20181201</startdate><enddate>20181201</enddate><creator>Ghandour, Rula</creator><creator>Mikki, Nahed</creator><creator>Abu Rmeileh, Niveen M.E.</creator><creator>Jerdén, Lars</creator><creator>Norberg, Margareta</creator><creator>Eriksson, Jan W.</creator><creator>Husseini, Abdullatif</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D93</scope><scope>DF2</scope><orcidid>https://orcid.org/0000-0001-8995-043X</orcidid><orcidid>https://orcid.org/0000-0001-8767-5956</orcidid></search><sort><creationdate>20181201</creationdate><title>Complications of type 2 diabetes mellitus in Ramallah and al-Bireh: The Palestinian Diabetes Complications and Control Study (PDCCS)</title><author>Ghandour, Rula ; Mikki, Nahed ; Abu Rmeileh, Niveen M.E. ; Jerdén, Lars ; Norberg, Margareta ; Eriksson, Jan W. ; Husseini, Abdullatif</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c464t-c0336b6cf2cbd37647238204910def385c93fc2c4753cac172effd221677dd893</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adult</topic><topic>anticoagulant agent</topic><topic>antidiabetic agent</topic><topic>antihypertensive agent</topic><topic>antilipemic agent</topic><topic>Arab</topic><topic>Arabs</topic><topic>biological marker</topic><topic>Biomarkers</topic><topic>blood</topic><topic>Blood Glucose</topic><topic>cardiac agent</topic><topic>cerebrovascular accident</topic><topic>Comorbidity</topic><topic>controlled study</topic><topic>coronary artery disease</topic><topic>Cross-Sectional Studies</topic><topic>cross-sectional study</topic><topic>Diabetes Complications</topic><topic>Diabetes Mellitus</topic><topic>diabetic complication</topic><topic>diabetic nephropathy</topic><topic>diabetic neuropathy</topic><topic>disease duration</topic><topic>epidemiology</topic><topic>ethnology</topic><topic>Female</topic><topic>glucose blood level</topic><topic>Glycated Hemoglobin A</topic><topic>Glycemic control</topic><topic>glycosylated hemoglobin</topic><topic>Health and Welfare</topic><topic>hemoglobin A1c</topic><topic>hemoglobin A1c protein</topic><topic>human</topic><topic>Humans</topic><topic>Hälsa och välfärd</topic><topic>insulin</topic><topic>laboratory test</topic><topic>Macrovascular complications</topic><topic>major clinical study</topic><topic>Male</topic><topic>metabolism</topic><topic>Microvascular complications</topic><topic>Middle Aged</topic><topic>Middle East</topic><topic>non insulin dependent diabetes mellitus</topic><topic>Palestinian</topic><topic>peripheral vascular disease</topic><topic>physical examination</topic><topic>Prevalence</topic><topic>Primary health care clinics</topic><topic>priority journal</topic><topic>risk factor</topic><topic>Risk Factors</topic><topic>Type 2</topic><topic>Type 2 diabetes</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ghandour, Rula</creatorcontrib><creatorcontrib>Mikki, Nahed</creatorcontrib><creatorcontrib>Abu Rmeileh, Niveen M.E.</creatorcontrib><creatorcontrib>Jerdén, Lars</creatorcontrib><creatorcontrib>Norberg, Margareta</creatorcontrib><creatorcontrib>Eriksson, Jan W.</creatorcontrib><creatorcontrib>Husseini, Abdullatif</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Umeå universitet</collection><collection>SWEPUB Uppsala universitet</collection><jtitle>Primary care diabetes</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ghandour, Rula</au><au>Mikki, Nahed</au><au>Abu Rmeileh, Niveen M.E.</au><au>Jerdén, Lars</au><au>Norberg, Margareta</au><au>Eriksson, Jan W.</au><au>Husseini, Abdullatif</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Complications of type 2 diabetes mellitus in Ramallah and al-Bireh: The Palestinian Diabetes Complications and Control Study (PDCCS)</atitle><jtitle>Primary care diabetes</jtitle><addtitle>Prim Care Diabetes</addtitle><date>2018-12-01</date><risdate>2018</risdate><volume>12</volume><issue>6</issue><spage>547</spage><epage>557</epage><pages>547-557</pages><issn>1751-9918</issn><issn>1878-0210</issn><eissn>1878-0210</eissn><abstract>•Persons with type 2 diabetes in 11 primary health care clinics were sampled.•Over three-quarters of the participants had at least one complication.•67% had at least one microvascular and 29% had at least 1 macrovascular complication.•Around one fifth of the participants had good glycemic control (HbA1c<7.0%).•89% had high blood pressure or were on anti-hypertensive medications.
Type 2 diabetes mellitus (T2DM) is a growing pandemic that will lead, if not managed and controlled, to frequent complications, poor quality of life, and high rates of disability and death. Little is known about T2DM complications in Palestine. The aim of this study is to estimate the prevalence of T2DM complications in Ramallah and al-Bireh governorate of Palestine.
The study was conducted in eleven primary healthcare clinics offering services for persons with T2DM. Macrovascular complications were assessed using the Diabetes complication index. Microvascular complications were measured by physical examinations and laboratory tests. Questionnaires, laboratory tests, and physical examinations were used to assess socio-demographic characteristics, co-morbidities and other risk factors.
517 adult men and nonpregnant women participated in the study (166 men, 351 women). The response rate was 84%. Mean age and mean duration of diabetes were 58.1 and 9.4 years respectively. Prevalence of diagnosed microvascular and macrovascular complications was 67.2% and 28.6% respectively. 78.2% of the participants had poor glycemic control (HbA1c≥7.0%).
Significant proportions of persons with T2DM had macro- and microvascular complications and poor metabolic control. These findings are important for policy development and the planning of health services.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>30072279</pmid><doi>10.1016/j.pcd.2018.07.002</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-8995-043X</orcidid><orcidid>https://orcid.org/0000-0001-8767-5956</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1751-9918 |
| ispartof | Primary care diabetes, 2018-12, Vol.12 (6), p.547-557 |
| issn | 1751-9918 1878-0210 1878-0210 |
| language | eng |
| recordid | cdi_swepub_primary_oai_DiVA_org_uu_372817 |
| source | Elsevier:Jisc Collections:Elsevier Read and Publish Agreement 2022-2024:Freedom Collection (Reading list) |
| subjects | Adult anticoagulant agent antidiabetic agent antihypertensive agent antilipemic agent Arab Arabs biological marker Biomarkers blood Blood Glucose cardiac agent cerebrovascular accident Comorbidity controlled study coronary artery disease Cross-Sectional Studies cross-sectional study Diabetes Complications Diabetes Mellitus diabetic complication diabetic nephropathy diabetic neuropathy disease duration epidemiology ethnology Female glucose blood level Glycated Hemoglobin A Glycemic control glycosylated hemoglobin Health and Welfare hemoglobin A1c hemoglobin A1c protein human Humans Hälsa och välfärd insulin laboratory test Macrovascular complications major clinical study Male metabolism Microvascular complications Middle Aged Middle East non insulin dependent diabetes mellitus Palestinian peripheral vascular disease physical examination Prevalence Primary health care clinics priority journal risk factor Risk Factors Type 2 Type 2 diabetes Young Adult |
| title | Complications of type 2 diabetes mellitus in Ramallah and al-Bireh: The Palestinian Diabetes Complications and Control Study (PDCCS) |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T16%3A45%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Complications%20of%20type%202%20diabetes%20mellitus%20in%20Ramallah%20and%20al-Bireh:%20The%20Palestinian%20Diabetes%20Complications%20and%20Control%20Study%20(PDCCS)&rft.jtitle=Primary%20care%20diabetes&rft.au=Ghandour,%20Rula&rft.date=2018-12-01&rft.volume=12&rft.issue=6&rft.spage=547&rft.epage=557&rft.pages=547-557&rft.issn=1751-9918&rft.eissn=1878-0210&rft_id=info:doi/10.1016/j.pcd.2018.07.002&rft_dat=%3Cproquest_swepu%3E2083714571%3C/proquest_swepu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c464t-c0336b6cf2cbd37647238204910def385c93fc2c4753cac172effd221677dd893%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2083714571&rft_id=info:pmid/30072279&rfr_iscdi=true |